Finance

Beta
Lists
VTR:NYSE
Ventas Inc
$83.04
0.00%
(0.00) 1D
Jun 22, 4:00:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTR...
Mkt. cap
40.37B
Avg. vol.
4.24M
Volume
34.00
Dividend
2.41%
Quarterly dividend
$0.50
Ex-dividend date
Jun 30, 2026
P/E ratio
150.45
52-wk high
$91.06
52-wk low
$61.76
EPS
$0.55
Beta
0.70
Shares outstanding
486.17M
No. of employees
542
Mkt. cap
40.37B
Avg. vol.
4.24M
Volume
34.00
Dividend
2.41%
Quarterly dividend
$0.50
Ex-dividend date
Jun 30, 2026
P/E ratio
150.45
52-wk high
$91.06
52-wk low
$61.76
EPS
$0.55
Beta
0.70
Shares outstanding
486.17M
No. of employees
542
News stories
From sources across the web
Profile
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom. As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion. As of 2019, it is a Fortune 1000 corporation. Wikipedia
About Ventas Inc
CEODebra Cafaro
Employees542
Founded1998
HeadquartersChicago, Illinois, United States
SectorReal estate investment trust
Analyst Ratings
Based on 16 analysts giving stock ratings to VTR in the past 3 months
Strong Buy
Buy
13
Hold
3
Sell
0
12 month forecast
Based on 16 Wall Street analysts offering 12 month price targets for VTR in the last 3 months.
Highest
Current $83.04
$110.00 (+32.47%)
Average
$97.31 (+17.18%)
Lowest
$88.00 (+5.97%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Nicholas Yulico
Scotiabank
Hold
Maintained
$88.00
+6%
06/18/2026
Unknown Analyst
Raymond James
Buy
Initiated
$94.00
+13.2%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
$94.00
+13.2%
06/16/2026
Omotayo Okusanya
Deutsche Bank
Buy
Maintained
$100.00
+20.4%
06/16/2026
Jeffrey Spector
Bank of America Securities
Buy
Maintained
$110.00
+32.5%
06/10/2026
Julien Blouin
Goldman Sachs
Buy
Maintained
$110.00
+32.5%
06/03/2026
Ronald Kamdem
Morgan Stanley
Hold
Reiterated
$90.00
+8.4%
06/02/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
$98.00
+18%
05/25/2026
Jonathan Petersen
Jefferies
Buy
Maintained
$100.00
+20.4%
05/12/2026
Michael Mueller
J.P. Morgan
Buy
Reiterated
$94.00
+13.2%
05/11/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
$95.00
+14.4%
05/07/2026
Juan C. Sanabria
BMO Capital
Buy
Maintained
$100.00
+20.4%
05/04/2026
Michael Goldsmith
UBS
Hold
Maintained
$93.00
+12%
05/04/2026
Nicholas Joseph
Citi
Buy
Reiterated
$100.00
+20.4%
05/01/2026
Michael Carroll
RBC Capital
Buy
Maintained
$98.00
+18%
05/01/2026
James Kammert
Evercore ISI
Buy
Maintained
$94.00
+13.2%
04/28/2026
John Kilichowski
Wells Fargo
Buy
Maintained
$93.00
+12%
03/26/2026
Marie Ferguson
Argus Research
Buy
Maintained
$88.00
+6%
02/09/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
$93.00
+12%
02/09/2026
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.10 / $0.10
-1.40%miss
Revenue / Est. (USD)
1.65B / 1.58B
+4.51%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.41B
1.50B
1.55B
1.65B
Cost of goods sold
826.90M
869.92M
937.40M
1.00B
Cost of revenue
826.90M
869.92M
937.40M
1.00B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42.86M
40.39M
41.01M
62.75M
Operating expense
355.68M
397.56M
297.53M
416.91M
Total operating expenses
1.18B
1.27B
1.23B
1.42B
Operating income
231.31M
233.98M
315.49M
226.81M
Other non operating income
-5.84M
-13.37M
-4.20M
-9.70M
EBT including unusual items
75.34M
62.36M
71.87M
43.11M
EBT excluding unusual items
81.05M
66.67M
164.69M
63.47M
Income tax expense
3.87M
-6.34M
-1.12M
-15.94M
Effective tax rate
5.14%
-10.17%
-1.56%
-36.97%
Other operating expenses
-
-
-
-
Net income
68.26M
66.05M
70.20M
55.91M
Net profit margin
4.83%
4.40%
4.53%
3.39%
Earnings per share
-
0.12
0.13
0.10
Interest and investment income
5.87M
4.18M
7.88M
2.50M
Interest expense
-150.30M
-158.12M
-154.47M
-156.14M
Net interest expenses
-144.43M
-153.94M
-146.59M
-153.64M
Depreciation and amortization charges
312.82M
357.17M
256.52M
354.17M
EBITDA
540.83M
559.73M
659.02M
585.75M
Gain or loss from assets sale
-33.82M
-1.28M
-3.31M
-15.06M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more